Cas no 27069-16-5 (3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid)

3-(4-Methoxyphenyl)-1H-pyrazole-5-carboxylic acid is a versatile heterocyclic compound featuring a pyrazole core substituted with a 4-methoxyphenyl group and a carboxylic acid functionality. This structure imparts significant utility in medicinal chemistry and organic synthesis, serving as a key intermediate for the development of pharmacologically active molecules. The methoxy group enhances electron density, influencing reactivity and binding interactions, while the carboxylic acid moiety allows for further derivatization, such as amide formation or esterification. Its well-defined chemical properties make it valuable for constructing targeted compounds in drug discovery, particularly in the design of enzyme inhibitors or receptor modulators. The compound is characterized by high purity and stability under standard conditions.
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid structure
27069-16-5 structure
Product Name:3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
CAS No:27069-16-5
MF:C11H10N2O3
MW:218.20870256424
MDL:MFCD03716564
CID:253597
PubChem ID:24882575
Update Time:2025-10-29

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid Chemical and Physical Properties

Names and Identifiers

    • 5-(4-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid
    • 1H-Pyrazole-3-carboxylicacid, 5-(4-methoxyphenyl)-
    • 3-(4-Methoxyphenyl)-1H-pyrazole-5-carboxylic acid
    • 5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
    • 5-(4-METHOXY-PHENYL)-2H-PYRAZOLE-3-CARBOXYLICACID
    • 5-(4-methoxy-phenyl)-1(2)H-pyrazole-3-carboxylic acid
    • 5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid(SALTDATA: FREE)
    • 5-(4-Methoxyphenyl)-2H-pyrazole-3-carboxylic acid
    • 5-(4-methoxyphenyl)pyrazole-3-carboxylic acid
    • 5-(4-Methoxy-phenyl)-2H-pyrazole-3-carboxylic acid
    • cid_1085887
    • BDBM45777
    • VHWPBROOEIJLIW-UHFFFAOYSA-N
    • ZX-CM0
    • BS-4260
    • EN300-83622
    • CS-W022248
    • AKOS000264928
    • BB 0258868
    • J-016668
    • MLS-0091962.0001
    • Z57044182
    • 5-(4-Methoxyphenyl)-1H-pyrazole-3-carboxylic acid, AldrichCPR
    • CHEMBL1532040
    • AB15826
    • DS-0120
    • 3-(4-Methoxyphenyl)-1H-pyrazole-5-carboxylic acid, 97%
    • 27069-16-5
    • AM20060584
    • VU0607276-1
    • SCHEMBL1413939
    • BDBM50096128
    • FT-0688914
    • SR-01000325126-1
    • BRD-K65870873-001-01-5
    • 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylicacid
    • J-516255
    • A877030
    • 1H-Pyrazole-3-carboxylicacid,5-(4-methoxyphenyl)-
    • BB 0217969
    • 5-p-methoxy-phenyl-3-pyrazolecarboxylic
    • AKOS000147051
    • MFCD03030168
    • F3250-0569
    • SCHEMBL14152359
    • SR-01000325126
    • MFCD03716564
    • DTXSID40949823
    • 890006-68-5
    • STK299947
    • ALBB-006557
    • DB-001927
    • BBL008305
    • 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
    • MDL: MFCD03716564
    • Inchi: 1S/C11H10N2O3/c1-16-8-4-2-7(3-5-8)9-6-10(11(14)15)13-12-9/h2-6H,1H3,(H,12,13)(H,14,15)
    • InChI Key: VHWPBROOEIJLIW-UHFFFAOYSA-N
    • SMILES: O(C)C1C=CC(=CC=1)C1C=C(C(=O)O)NN=1

Computed Properties

  • Exact Mass: 218.06900
  • Monoisotopic Mass: 218.06914219g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 3
  • Complexity: 252
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: 4
  • XLogP3: 1.7
  • Topological Polar Surface Area: 75.2

Experimental Properties

  • Color/Form: Not available
  • Density: 1.3±0.1 g/cm3
  • Melting Point: 221-225?°C (lit.)
  • Boiling Point: 516.9±45.0 °C at 760 mmHg
  • Flash Point: 266.4±28.7 °C
  • PSA: 75.21000
  • LogP: 1.78350
  • Solubility: Not available

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid Security Information

  • Symbol: GHS07
  • Signal Word:Warning
  • Hazard Statement: H315-H319-H335
  • Warning Statement: P261-P305 + P351 + P338
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:3
  • Hazard Category Code: 36/37/38
  • Safety Instruction: S26; S36
  • Hazardous Material Identification: Xi
  • Risk Phrases:R36/37/38
  • HazardClass:IRRITANT
  • Storage Condition:Sealed in dry,2-8°C

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid Customs Data

  • HS CODE:2933199090
  • Customs Data:

    China Customs Code:

    2933199090

    Overview:

    2933199090. Other structurally non fused pyrazole ring compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Fluorochem
028078-1g
5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
27069-16-5 95%
1g
£16.00 2022-03-01
Fluorochem
028078-5g
5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
27069-16-5 95%
5g
£60.00 2022-03-01
Fluorochem
028078-10g
5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
27069-16-5 95%
10g
£110.00 2022-03-01
Fluorochem
028078-25g
5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
27069-16-5 95%
25g
£218.00 2022-03-01
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
M169184-25g
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
27069-16-5 97%
25g
¥1970.90 2023-09-01
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
M169184-1g
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
27069-16-5 97%
1g
¥154.90 2023-09-01
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
M169184-10g
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
27069-16-5 97%
10g
¥985.90 2023-09-01
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
M169184-250mg
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
27069-16-5 97%
250mg
¥61.90 2023-09-01
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
M169184-5g
3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid
27069-16-5 97%
5g
¥616.90 2023-09-01
Chemenu
CM188001-5g
5-(4-Methoxy-phenyl)-1H-pyrazole-3-carboxylic acid
27069-16-5 95+%
5g
$102 2021-08-05

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid Production Method

Additional information on 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid

Professional Introduction to 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic Acid (CAS No. 27069-16-5)

3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid, with the CAS number 27069-16-5, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic organic compound has garnered attention due to its versatile structural framework and potential applications in drug discovery and development. The presence of a pyrazole core, combined with a methoxy-substituted phenyl group, makes it a valuable scaffold for designing molecules with enhanced biological activity.

The pyrazole moiety is a six-membered aromatic ring containing two adjacent nitrogen atoms, which is known for its ability to interact with various biological targets. This structural feature has been widely exploited in the development of drugs targeting inflammatory diseases, antimicrobial infections, and even cancer. The carboxylic acid functional group at the 5-position of the pyrazole ring further extends its utility, allowing for further derivatization and modification to tailor specific pharmacological properties.

In recent years, there has been a surge in research focusing on natural product-inspired scaffolds due to their proven efficacy and minimal side effects. 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid fits well within this paradigm, as it can be derived from or inspired by naturally occurring compounds. Studies have shown that compounds containing the pyrazole core exhibit promising activities against various disease states, making them attractive candidates for further investigation.

The methoxy group on the phenyl ring in 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid plays a crucial role in modulating the compound's pharmacokinetic properties. Methoxy-substituted aromatic rings are known to enhance lipophilicity, which can improve oral bioavailability and tissue penetration. This characteristic is particularly important in drug design, as it ensures that the active molecule can reach its target site effectively.

Recent advancements in computational chemistry have enabled researchers to predict the biological activity of molecules with high accuracy before conducting expensive wet-lab experiments. Virtual screening techniques have been employed to identify potential hits from large databases of compounds, including derivatives of 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid. These computational methods have accelerated the drug discovery process significantly, allowing for rapid identification of lead compounds that can be further optimized.

The synthesis of 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid involves multi-step organic reactions that require precise control over reaction conditions. Common synthetic routes include condensation reactions between appropriately substituted hydrazines and β-ketoesters or β-diketones. The choice of starting materials and reagents can influence the yield and purity of the final product, making optimization a critical step in the synthetic process.

In addition to its potential as an active pharmaceutical ingredient (API), 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid can serve as an intermediate in the synthesis of more complex molecules. Its structural versatility allows for modifications at multiple positions, enabling the creation of libraries of derivatives with diverse biological activities. Such libraries are invaluable tools in high-throughput screening (HTS) campaigns aimed at identifying novel drug candidates.

The pharmacological profile of derivatives of 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid has been extensively studied in various preclinical models. Initial findings suggest that these compounds exhibit anti-inflammatory, antimicrobial, and even antitumor properties. For instance, some derivatives have shown promising results in inhibiting key enzymes involved in inflammatory pathways, such as COX-2 and LOX enzymes. These activities make them attractive candidates for further development into therapeutic agents.

The growing interest in green chemistry has also influenced the synthesis of 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid. Researchers are increasingly exploring solvent-free reactions, catalytic methods, and biocatalysis to minimize waste and improve efficiency. These sustainable approaches not only reduce environmental impact but also often enhance reaction yields and scalability, making them economically viable for industrial applications.

The future prospects for 3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylic acid and its derivatives are bright, with ongoing research aimed at uncovering new biological activities and optimizing their pharmacological properties. Advances in synthetic methodologies will continue to play a crucial role in this endeavor, enabling the rapid development of novel therapeutic agents based on this promising scaffold.

Recommended suppliers
TAIXING JOXIN BIO-TEC CO.,LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
TAIXING JOXIN BIO-TEC CO.,LTD.
Wuhan ChemNorm Biotech Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Wuhan ChemNorm Biotech Co.,Ltd.
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
ASIACHEM I&E (JIANGSU) CO., LTD
Yunnanjiuzhen
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.